Vial’s newly launched contract research organization (CRO) addressed ways to surmount some of the biggest obstacles blocking increased speed and quality of clinical trials with an advisory board meeting at Maui Derm for Dermatologists 2022.

Melanoma in Black patients presents unique challenges for dermatologists due to clinical diagnostic differences, provider bias, and a lack of patient awareness, according to a presentation given at Maui Derm 2022.

Neal Bhatia, MD, highlights the most exciting new drugs and therapies in atopic dermatitis and psoriasis in his presentation at the current Maui Derm for Dermatologists meeting.

Patients suffering from several dermatologic diseases and conditions including acne, rosacea, and pruritus can largely benefit from the new and exciting therapies and treatment modalities that have recently become available.

Maui Derm begins today in Maui, Hawaii, offering a multitude of presentations and workshops for the dermatology community.

Vial announced an advisory board to discuss dermatology CROs at the 2022 Winter Clinical Dermatology Conference.

The FDA approved the topical JAK1/JAK2 inhibitor ruxolitinib for the treatment of mild to moderate atopic dermatitis in September 2021.

Treating these patients can be a challenge, but it can also be ‘as easy as pie’ if you follow these tips.

One of the key differences between diagnosing AD in patients with skin of color compared to White skin is erythema.

AAD vice president challenges dermatologists to advocate for their patients and themselves.

Targeting skin care regimens to the individual patient is most likely to yield compliance to a recommended routine.

Resident billing can have huge financial implications on academic institutions. A poster from the Icahn School of Medicine at Mount Sinai aimed to assess new medical coding lectures and a modified note template at Winter Clinical Dermatology Conference.

More trustworthy sources of information, and data, are needed.

As skin manifestations are commonly the first thing spotted with infectious disease, dermatologists are in a great position to counsel patients about prevention.

Studies offer positive outcomes for patients with conditions like hidradenitis suppurativa or psoriasis.

Sunscreen advice, recruiting during the “Great Recession”, and tips for the office led the busy agenda at Winter Clinical Dermatology Conference this weekend.

What new treatments are coming to infectious disease? How can they be prevented and what misconceptions are affecting treatment? Learn about this and more in this video with Ted Rosen, MD.

Ted Rosen, MD, explains the top points of his presentation, "What's Hot and New in Infectious Disease?" from the 2022 Winter Clinical Dermatology Conference.

Treatments awaiting FDA approval could bolster the range of nonsteroids and well-tolerated topicals aimed at combating pediatric cutaneous disorders.

In this video interview, Peter A. Lio, MD, FAAD, expands on his Winter Clinical Dermatology 2022 presentation, "What's Hot and New in Pediatric Dermatology?" He talks the pipeline, black box warnings, and more on atopic dermatitis treatments.